Kymos Pharma Services, a Contract Research Organization (CRO), has signed a collaboration deal with agreement with pharmaceutical company, Ipsen to develop R&D services in the field of bio molecules and biosimilars.
Subscribe to our email newsletter
Kymos plans to take up research activities in a new immunology laboratory that will be opened in the Barcelona Science Park (PCB) in early January 2012, conducting regulatory development projects for biotech companies.
Kymos strategic general manager Joan Puig said the agreement would bolster the company’s growth strategy.
"The agreement also speeds up our international expansion plans, thus our company will be the only Spanish CRO and one of the few European ones that will be able to offer comprehensive services for biotech companies according to Good Laboratory Practices and Good Manufacturing Practices," Puig added.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.